{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T09:13:40Z","timestamp":1774862020656,"version":"3.50.1"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[1992,12,1]],"date-time":"1992-12-01T00:00:00Z","timestamp":723168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1992,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We investigated the assumption that the efficacy of inhaled diuretics in asthma is dependent upon inhibition of the Na+K+\/2Cl\u2212cotransporter. We compared the protective effect of acetazolamide, a diuretic without significant effect on the loop cotransporter, with the protection provided by inhaled furosemide in a cold, dry air hyperventilation model of asthma. Seven asthmatic subjects underwent a baseline bronchial challenge and then received a nebulized dose of 80 mg of furosemide or 500 mg of acetazolamide or saline placebo in a randomized, double-blind, placebo-controlled crossover design. Repeat challenges were performed immediately and at 2 and 4 h post-nebulization. Acetazolamide caused a 47.2% increase in the amount of cold, dry air required to reduce the FEV1 by 20% (expressed in terms of respiratory heat loss as PD20RHL), from 0.79 multiplied or divided by (\u00d7\/\u00f7) 1.13 kcal\/min (geometric mean \u00d7\/\u00f7 geometric SEM) at baseline to 1.17 \u00d7\/\u00f7 1.09 kcal\/min postnebulization (p &amp;lt; 0.025). Furosemide increased the geometric mean PD20RHL by 53.9%, from 0.86 \u00d7\/\u00f7 1.12 kcal\/min to 1.33 \u00d7\/\u00f7 1.12 kcal\/min (p &amp;lt; 0.001). There was no significant change after placebo inhalation (0.81 \u00d7\/\u00f7 1.15 kcal\/min versus 0.87 \u00d7\/\u00f7 1.10 kcal\/min, NS). Airway responsiveness had returned to baseline by 2 h postnebulization on all 3 days. Furosemide also caused bronchodilatation, producing a 14.1% rise in the mean FEV1 (p &amp;lt; 0.005 versus prenebulization), whereas neither acetazolamide nor placebo altered airway tone significantly. In addition, urine output in the 4 h after nebulization increased from a mean of 270 \u00b1 120 ml postplacebo to 690 \u00b1 170 ml after acetazolamide (0.05 &amp;lt; p &amp;lt; 0.10) and 1,350 \u00b1 200 ml after furosemide administration (p &amp;lt; 0.025 versus acetazolamide and p &amp;lt; 0.005 versus placebo); both drugs affected urinary pH. These results demonstrate that acetazolamide, a diuretic lacking loop diuretic activity, can inhibit experimental asthma. This finding suggests that an inhaled diuretic need not inhibit the loop diuretic-sensitive Na+\/K+\/2Cl\u2212 cotransporter in order to attenuate the asthmatic response to a bronchoconstrictor Stimulus.<\/jats:p>","DOI":"10.1164\/ajrccm\/146.6.1518","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T17:39:16Z","timestamp":1365097156000},"page":"1518-1523","source":"Crossref","is-referenced-by-count":40,"title":["Acetazolamide and Furosemide Attenuate Asthma Induced by Hyperventilation of Cold, Dry Air"],"prefix":"10.1093","volume":"146","author":[{"given":"Walter J.","family":"O'Donnell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph W.","family":"Niven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey M.","family":"Drazen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliot","family":"Israel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1992,12,1]]},"reference":[{"key":"p_3","first-page":"252","volume":"2","year":"1988","journal-title":"Lancet"},{"key":"p_12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198910193211602"},{"key":"p_16","doi-asserted-by":"publisher","DOI":"10.1136\/thx.45.5.377"},{"key":"p_21","first-page":"10","volume":"85","year":"1990","journal-title":"Clin Immunol"},{"key":"p_27","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1164\/ajrccm\/143.6.1329","volume":"143","year":"1991","journal-title":"Respir Dis"},{"key":"p_31","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1183\/09031936.93.03060665","volume":"3","year":"1990","journal-title":"Eur Respir J"},{"key":"p_41","first-page":"187","volume":"1","year":"1989","journal-title":"PulmonPharmacol"},{"key":"p_55","doi-asserted-by":"crossref","first-page":"C177","DOI":"10.1152\/ajpcell.1987.253.2.C177","volume":"253","year":"1987","journal-title":"Am J Physiol"},{"key":"p_59","first-page":"1340","volume":"143","year":"1991","journal-title":"Dis"},{"key":"p_61","first-page":"1539","volume":"335","year":"1990","journal-title":"Lancet"},{"key":"p_68","first-page":"146","volume":"17","year":"1986","journal-title":"J Pharmacol"},{"key":"p_73","first-page":"92","volume":"227","year":"1983","journal-title":"Ther"},{"key":"p_77","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/136.1.225"},{"key":"p_81","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1152\/jappl.1979.46.3.467","volume":"46","year":"1979","journal-title":"J Appl Physiol"},{"key":"p_98","first-page":"331","volume":"71","year":"1983","journal-title":"Clin Immunol"},{"key":"p_110","first-page":"219","volume":"71","year":"1983","journal-title":"Bioi"},{"key":"p_135","first-page":"194","volume":"189","year":"1974","journal-title":"J Pharmacol Exp Ther"},{"key":"p_139","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1164\/ajrccm\/142.1.73","volume":"142","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"p_142","first-page":"131","volume":"324","year":"1991","journal-title":"N Engl J Med"},{"key":"p_150","first-page":"421","volume":"48","year":"1975","journal-title":"Clin Sci Mol Med"}],"container-title":["American Review of Respiratory Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/146\/6\/1518\/67643570\/ajrccm_146_6_1518.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/146\/6\/1518\/67643570\/ajrccm_146_6_1518.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:27:31Z","timestamp":1774859251000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/146\/6\/1518\/8557304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,12,1]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[1992,12,1]]},"published-print":{"date-parts":[[1992,12,1]]}},"URL":"https:\/\/doi.org\/10.1164\/ajrccm\/146.6.1518","relation":{},"ISSN":["0003-0805"],"issn-type":[{"value":"0003-0805","type":"print"}],"subject":[],"published-other":{"date-parts":[[1992,12]]},"published":{"date-parts":[[1992,12,1]]}}}